Mirae Asset Global ETFs Holdings’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,132
Closed -$18.8K 3208
2024
Q2
$18.8K Buy
+1,132
New +$18.8K ﹤0.01% 2928